4.5 Editorial Material

Prophecy or empiricism? Clinical value of predicting versus determining genetic variant functions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Gene variant effects across sodium channelopathies predict function and guide precision therapy

Andreas Brunklaus et al.

Summary: Pathogenic variants in the voltage-gated sodium channel gene family have diverse functional effects and can lead to various diseases. This study investigates the similarities in biophysical properties between different sodium channel genes and suggests that these similarities can be used to predict channel function and guide precision therapy. The results show that disease-associated variants cluster in specific functional domains, while population variants are more frequent in non-conserved domains.
Article Clinical Neurology

Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort

David Baez-Nieto et al.

Summary: This study characterized the functional effects of CACNA1I variants in a Swedish schizophrenia cohort and found that rare variants from schizophrenia patients mainly alter the activation of the Ca(V)3.3 channel by voltage, whereas variants from control subjects are typically associated with reduced Ca(V)3.3 protein expression.
Article Biochemical Research Methods

NeuroGPU: Accelerating multi-compartment, biophysically detailed neuron simulations on GPUs

Roy Ben-Shalom et al.

Summary: The membrane potential of individual neurons is influenced by a complex interaction of biophysical processes, requiring detailed simulations for accurate prediction. NeuroGPU uses GPU parallelization to accelerate neuronal simulation, outperforming other methods in speed and efficiency for parameter tuning and large-scale exploration. By utilizing multiple GPUs, NeuroGPU can achieve up to an 800-fold speed-up in simulations, showing great potential for rapid and accurate modeling of biophysically detailed neuron models.

JOURNAL OF NEUROSCIENCE METHODS (2022)

Article Genetics & Heredity

A massively parallel assay accurately discriminates between functionally normal and abnormal variants in a hotspot domain of KCNH2

Chai-Ann Ng et al.

Summary: This study used a massively parallel trafficking assay to characterize single-nucleotide variants in exon 2 of the KCNH2 gene, finding that 42% of variants caused at least a 50% reduction in protein trafficking, and 65% of these variants showed a dominant-negative effect when co-expressed with a WT KCNH2 allele. The massively parallel trafficking assay was more accurate in discriminating between functionally normal and abnormal variants compared to bioinformatic prediction tools.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Clinical Neurology

The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications

Andreas Brunklaus et al.

Summary: This study describes different phenotypes of SCN1A-related epilepsy, some of which are associated with febrile seizures and familial hemiplegic migraine. The research found that these phenotypes are caused by SCN1A variants, and by conducting clinical, genetic, and functional evaluations of the affected individuals, it reveals the potential efficacy of sodium channel blockers in treating this disease.
Review Clinical Neurology

Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress

Juliet K. Knowles et al.

Summary: The genetic basis of epilepsy is becoming better understood, opening up the possibility for precision treatments based on specific genetic causes. However, current medical therapy for epilepsy is still imprecise and mainly focused on reducing seizures empirically. Despite significant advancements in diagnosis and technology, there has been limited impact on clinical practice. Nevertheless, the epilepsy community is poised to make significant progress in precision therapy through continued innovations in gene discovery, diagnostics, and bioinformatics, increased accessibility to genetic testing, and a greater understanding of the natural course of the disease.

EPILEPSIA (2022)

Article Clinical Neurology

Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice

Dianalee McKnight et al.

Summary: This study on the association between genetic diagnosis and clinical management and outcomes of patients with epilepsy suggests that genetic testing may play a significant role in clinical decision-making and improve patient outcomes.

JAMA NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Identification of pathogenic variant enriched regions across genes and gene families

Eduardo Perez-Palma et al.

GENOME RESEARCH (2020)

Article Cell Biology

Predicting functional effects of missense variants in voltage-gated sodium and calcium channels

Henrike O. Heyne et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Clinical Neurology

SCN1A gain of function in early infantile encephalopathy

Geza Berecki et al.

ANNALS OF NEUROLOGY (2019)

Article Biochemical Research Methods

Estimating neuronal conductance model parameters using dynamic action potential clamp

Y. Deerasooriya et al.

JOURNAL OF NEUROSCIENCE METHODS (2019)

Article Clinical Neurology

Spectrum of KV2.1 Dysfunction in KCNB1-Associated Neurodevelopmental Disorders

Seok Kyu Kang et al.

ANNALS OF NEUROLOGY (2019)

Article Multidisciplinary Sciences

Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy

Geza Berecki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)